Combined Antidepressant Therapy-Reference-Cited by-同舟云学术

Combined Antidepressant Therapy

Published:1971-03 Issue:544 Volume:118 Page:301-304
ISSN:0007-1250
Container-title:British Journal of Psychiatry
language:en
Short-container-title:Br J Psychiatry

Author:

Winston Frank

Abstract

It is still generally believed that it is dangerous to combine the tricyclic antidepressants with any of the M.A.O. inhibitors, and the Federal Drug Administration, the Witts Committee and the drug manufacturers caution against so doing. Several current texts reiterate these warnings. (Beck, 1967; Malitz, 1966: Shepherd et al., 1968).

Publisher

Royal College of Psychiatrists

Subject

Psychiatry and Mental health

Reference14 articles.

1. ‘Combining the antidepressant drugs.’;Beresford Davies;Lancet,1963

2. Beck A. T. (1967). Depression: Clinical, Experimental, and Theoretical Aspects. New York, p. 304.

3. THE CATECHOLAMINE HYPOTHESIS OF AFFECTIVE DISORDERS: A REVIEW OF SUPPORTING EVIDENCE

4. New Theory of Cerebral Amine Function and its Clinical Application

5. Physiologic Responses as Prognostic Guides in the Use of Antidepressant Drugs

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The prescriber’s guide to classic MAO inhibitors (phenelzine, tranylcypromine, isocarboxazid) for treatment-resistant depression;CNS Spectrums;2022-07-15

2. Behandlung depressiver Störungen;Polypharmazie in der Behandlung psychischer Erkrankungen;2015-11-25

3. Polypharmazie in der Behandlung depressiver Störungen;Polypharmazie in der Behandlung psychischer Erkrankungen;2009

4. Monoamin-Oxidase-Hemmer;Neuro-Psychopharmaka Ein Therapie-Handbuch;2002

5. Strategies for Treatment Refractory Depression;Journal of Pharmacy Practice;2001-12